Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Case-Control Study of Risk Factors for Hepatitis B Infection: A Regional Report Among Isfahanian Adults Publisher



Ataei B1 ; Alavian SM2 ; Shahriarifard F3 ; Rabiei AA4 ; Safaei A3 ; Rabiei A2, 3 ; Ataei M5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Infectious Diseases, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Baghiatallah Research Center for Gastroenterology and Liver Diseases, Baghiatallah University of Medical Sciences, Tehran, Iran
  3. 3. Isfahan Medical School Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Department of Anatomical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2019


Abstract

Background: Hepatitis B is one of the major causes of mortality among viral diseases. To reduce morbidity rate and increase knowledge of people about potential risk factors, the aim of this study was to determine the prevalence of hepatitis B among the general population and the risk factors associated with hepatitis B virus (HBV) infection in Isfahan, Iran. Materials and Methods: In a case-control study, 314 HBV-infected patients and 557 healthy participants were recruited. Data on demographics, immunization history, medical history, family medical history, life history, therapeutic factors, and behavioral risk factors were collected through a standard checklist. Chi-square and logistic regression were used for univariate and multivariable analyses. Results: Our results showed that among sociodemographic variables, higher age, being male, lower economic status, and lower educational attainments increased the risk of affecting by HBV (odds ratio [OR] >1, P < 0.001); furthermore, Iranian and no immigrant people showed higher significant risk of being affected by HBV. Multivariable logistic regression showed among medical, blood, and behavioral risk factors, family history of hepatitis (OR: 10.56; 95% confidence interval [CI]: 4.56-24.86), dental treatment history (OR: 4.30; 95% CI: 1.41-13.10), and hospitalization (OR: 2.94; 95% CI: 1.72-5.00). Conclusion: Our results demonstrated that there are still several risk factors for hepatitis B surface antigen infection among the Iranian adult population. Immunization programs should continue and focus on high-risk adults, and interventions should be directed toward to reduce risk factors associated with hepatitis B. © 2019 Journal of Research in Medical Sciences | Published by Wolters Kluwer - Medknow.
Related Docs
View other Related Docs
1. Prevalence and Risk Factors of Hepatitis B Infection in Injection Drug Users, Tehran (2001-2002), Hepatitis Monthly (2008)
2. The Prevalence of Hepatitis B, Hepatitis C and Associated Risk Factors in Intravenous Drug Addicts (Ivda) With Hiv in Isfahan, Journal of Isfahan Medical School (2008)
3. Seroprevalence of Hepatitis B Infection and Associated Risk Factors Among Drug Users in Drop-In Centers of Isfahan, Iran, International Journal of Preventive Medicine (2018)
4. Hepatitis B Markers in Isfahan, Central Iran: A Population-Based Study, Hepatitis Monthly (2009)
5. How Much Does Vaccination Reduce the Rate of Hbv Infection in Iranian Population? a Bayesian Adjustment Analysis, Gastroenterology and Hepatology from Bed to Bench (2019)
6. Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran, Hepatitis Monthly (2017)
7. Assessment of Hepatitis C Risk Factors in Center of Iran: A Case-Control Study, Journal of Research in Medical Sciences (2018)
8. Comparison of the Prevalence and Risk Factors of Hepatitis a in 10 to 18-Year-Old Adolescents of Sixteen Iranian Provinces: The Caspian-Iii Study, Hepatitis Monthly (2016)
Experts (# of related papers)
View all Related Experts
Behrooz Ataei (38)
Zary Nokhodian (26)
Other Related Docs
9. Seroprevalence of Hepatitis B Markers Among Incarcerated Intravenous Drug Users, Journal of Research in Medical Sciences (2014)
10. Co-Infection of Human Immunodeficiency Virus, Hepatitis C and Hepatitis B Virus Among Injection Drug Users in Drop in Centers, Journal of Research in Medical Sciences (2014)
11. Prevalence of Anti Hcv Infection in Patients With Beta-Thalassemia in Isfahan-Iran, International Journal of Preventive Medicine (2012)
12. Seroprevalence of Hepatitis a in Patients With Chronic Hepatitis C in Isfahan Province, International Journal of Preventive Medicine (2012)
13. Prevalence of Hepatitis B Virus Infection in Isfahan Province, International Journal of Preventive Medicine (2014)
14. Seroprevalence of Hepatitis B in Nahavand, Islamic Republic of Iran, Eastern Mediterranean Health Journal (2006)
15. Seroprevalence of Hepatitis a Virus in Patients With Chronic Hepatitis B or C in Isfahan Province, Iran, Journal of Isfahan Medical School (2012)
16. Hepatitis B and C Among Patients Infected With Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors, Hepatitis Monthly (2010)
17. Hepatitis D Virus Infection in Isfahan, Central Iran: Prevalence and Risk Factors Among Chronic Hbv Infection Cases, Hepatitis Monthly (2011)
18. Seroprevalence of Hepatitis a Among Street Children, Isfahan, Iran, Journal of Isfahan Medical School (2012)
19. Global, Regional, and National Burden of Hepatitis B, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)
20. Cardiovascular Risk Factors and Clinical Outcomes Among Patients Hospitalized With Covid-19: Findings From the World Heart Federation Covid-19 Study, Global Heart (2022)
21. Hepatitis C in Patients With Multi Blood Transfusion, Journal of Isfahan Medical School (2011)
22. Effectiveness of Hepatitis B Vaccination in Children of Chronic Hepatitis B Mothers, Saudi Medical Journal (2004)
23. Seroprevalence of Hepatitis C Infection Among Laboratory Health Care Workers in Isfahan, Iran, International Journal of Preventive Medicine (2012)
24. Attitudes Towards Maternal Screening for Hepatitis B Virus Infection in Iran., Tropical gastroenterology : official journal of the Digestive Diseases Foundation (2010)
25. Effect of Tetanus-Diphtheria (Td) Vaccine on Immune Response to Hepatitis B Vaccine in Healthy Individuals With Insufficient Immune Response, Journal of Research in Medical Sciences (2015)
26. Hepatitis C Virus Infection in Patients With Hemophilia in Isfahan, Iran, International Journal of Preventive Medicine (2012)
27. Hepatitis C Among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors, International Journal of Preventive Medicine (2012)
28. Correlation Between Il-28 Polymorphism and Spontaneous Clearance in Hcv Patients: Systematic Review and Meta-Analysis, Archives of Virology (2021)
29. Comparing the Effectiveness of a Short-Term Double-Dose Hepatitis B Vaccination Schedule With the Standard 3-Dose Schedule: A Randomized Clinical Trial, Tehran University Medical Journal (2011)
30. Seroprevalence of Hbv, Hcv and Hiv Infection Among Intravenous Drug Users in Shahr-E-Kord, Islamic Republic of Iran, Eastern Mediterranean Health Journal (2008)
31. Seroprevalence of Hepatitis a in Iranian Adolescents: Is It Time to Introduce a Vaccine?, Epidemiology and Infection (2016)
32. Hepatitis C Virus and Associated Risk Factors Among Prison Inmates With History of Drug Injection in Isfahan, Iran, International Journal of Preventive Medicine (2012)
33. Prevalence and Risk Factors for Hepatitis B and Hepatitis C Exposure in Iranian Prisoners: A National Study in 2016, Hepatitis Monthly (2019)
34. Factors Related to Preventive Covid-19 Behaviors Using Health Belief Model Among General Population: A Cross-Sectional Study in Iran, BMC Public Health (2021)
35. Prevalence of Hbv and Hcv Infections and Associated Risk Factors in Addict Prisoners, Iranian Journal of Public Health (2006)
36. Seroepidemiology of Hepatitis a Virus Infections in Over 6-Years Population in Isfahan–Iran: A Community-Based Study, Journal of Isfahan Medical School (2007)
37. Seroprevalence of Hepatitis B Virus Infection and Hepatitis B Surface Antibody Status Among Laboratory Health Care Workers in Isfahan, Iran, Asian Journal of Transfusion Science (2015)
38. The Relative Frequency of Depression and Anxiety in Patients With Hepatitis B Referring to Infectious Diseases and Tropical Medicine Research Center, Isfahan, Iran, Journal of Isfahan Medical School (2012)
39. Comparison of Hbs-Antibody Serum Levels Between Patients With Type 2 Diabetes Mellitus and Controls Following Vaccination Against Hepatitis B, Journal of Isfahan Medical School (2007)
40. Effect of Tetanus-Diphtheria Vaccine on Immune Response to Hepatitis B Vaccine in Low-Responder Individuals, International Journal of Preventive Medicine (2016)
41. Risk Prison and Hepatitis B Virus Infection Among Inmates With History of Drug Injection in Isfahan, Iran, The Scientific World Journal (2013)
42. Seroprevalence of Hepatitis B Virus and Human Immunodeficiency Virus Among Young Prisoners, Journal of Research in Medical Sciences (2013)
43. Hepatitis C in Correctional Centers: A Useful Experience, Journal of Isfahan Medical School (2011)
44. Prevalence and Risk Factors of Hiv, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran, Hepatitis Monthly (2012)
45. Attitudes Towards Premarital Screening for Hepatitis B Virus Infection in Iran, Journal of Medical Screening (2007)
46. Hepatitis a Seropositivity Among Newly Admitted Medical Students of Isfahan, Kermanshah, and Hamedan: A Seroprevalence Study, Journal of Research in Medical Sciences (2014)
47. Hepatitis B Virus Genotype, Hbsag Mutations and Co-Infection With Hcv in Occult Hbv Infection, Clinics and Research in Hepatology and Gastroenterology (2011)
48. The Estimation of Direct Medical Costs of Treating Patients With Chronic Hepatitis B and C in Iran, International Journal of Preventive Medicine (2012)
49. Correlates of Injecting Paraphernalia Sharing Among Male Drug Injectors in Kermanshah, Iran: Implications for Hcv Prevention, Journal of Substance Use (2020)
50. Hepatitis B Virus Genotype D Is the Only Genotype Circulating in Iranian Chronic Carriers, the Unique Pattern of Genotypic Homogeneity, Journal of Gastroenterology and Hepatology Research (2014)